These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 12706644
1. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro). Meyer M, Kutscher G, Stürzebecher J, Riesener G, Lutze G. Thromb Res; 2003 Jan 25; 109(2-3):145-51. PubMed ID: 12706644 [Abstract] [Full Text] [Related]
2. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions. Soya K, Terasawa F, Okumura N. Thromb Haemost; 2013 Feb 25; 109(2):221-8. PubMed ID: 23238100 [Abstract] [Full Text] [Related]
3. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. Stucki B, Zenhäusern R, Biedermann B, Baudo F, Redaelli R, Lämmle B, Furlan M. Blood Coagul Fibrinolysis; 1999 Mar 25; 10(2):93-9. PubMed ID: 10192658 [Abstract] [Full Text] [Related]
4. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine. Yoshida N, Wada H, Morita K, Hirata H, Matsuda M, Yamazumi K, Asakura S, Shirakawa S. Blood; 1991 May 01; 77(9):1958-63. PubMed ID: 2018836 [Abstract] [Full Text] [Related]
5. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization. Lee MH, Kaczmarek E, Chin DT, Oda A, McIntosh S, Bauer KA, Clyne LP, McDonagh J. Blood; 1991 Oct 01; 78(7):1744-52. PubMed ID: 1912564 [Abstract] [Full Text] [Related]
6. Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution. Southan C, Lane DA, Bode W, Henschen A. Eur J Biochem; 1985 Mar 15; 147(3):593-600. PubMed ID: 3979390 [Abstract] [Full Text] [Related]
7. [Functional analysis for dysfibrinogenemias, Toyama and Adachi, which have a mutation of Aalpha16Arg-->His (CGT-->CAT) with aberrant fibrinopeptide A release]. Soya K, Takezawa Y, Terasawa F, Okumura N. Rinsho Byori; 2012 Jun 15; 60(6):499-505. PubMed ID: 22880226 [Abstract] [Full Text] [Related]
8. A novel variant fibrinogen, AαE11del, demonstrating the importance of AαE11 residue in thrombin binding. Kaido T, Yoda M, Kamijo T, Arai S, Yamauchi K, Okumura N. Int J Hematol; 2021 Nov 15; 114(5):591-598. PubMed ID: 34333754 [Abstract] [Full Text] [Related]
9. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R. Bolliger-Stucki B, Lord ST, Furlan M. Blood; 2001 Jul 15; 98(2):351-7. PubMed ID: 11435303 [Abstract] [Full Text] [Related]
10. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'. Okumura N, Terasawa F, Haneishi A, Fujihara N, Hirota-Kawadobora M, Yamauchi K, Ota H, Lord ST. J Thromb Haemost; 2007 Dec 15; 5(12):2352-9. PubMed ID: 17922804 [Abstract] [Full Text] [Related]
14. Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin. Vu TT, Stafford AR, Leslie BA, Kim PY, Fredenburgh JC, Weitz JI. J Biol Chem; 2013 Jun 07; 288(23):16862-16871. PubMed ID: 23612970 [Abstract] [Full Text] [Related]
15. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization. Tanaka H, Terasawa F, Ito T, Tokunaga S, Ishida F, Kitano K, Kiyosawa K, Okumura N. Thromb Haemost; 2001 Jan 07; 85(1):108-13. PubMed ID: 11204560 [Abstract] [Full Text] [Related]
16. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide. Lane DA, Southan C, Ireland H, Thompson E, Kehl M, Henschen A. Br J Haematol; 1983 Apr 07; 53(4):587-97. PubMed ID: 6830702 [Abstract] [Full Text] [Related]
17. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release. Yan J, Luo M, Cheng P, Liao L, Deng X, Deng D, Lin F. Int J Hematol; 2017 Apr 07; 105(4):506-514. PubMed ID: 27933517 [Abstract] [Full Text] [Related]
18. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency. Bögli C, Cofrancesco E, Cortellaro M, Della Volpe A, Hofer A, Furlan M, Zanussi C. Eur J Haematol; 1990 Jul 07; 45(1):26-30. PubMed ID: 2379562 [Abstract] [Full Text] [Related]
19. Fibrinogen Saint-Germain I: a case of the heterozygous Aalpha GLY 12 --> VAL fibrinogen variant. Mathonnet F, Peltier JY, Detruit H, de Raucourt E, Alvarez JC, Mazmanian GM, de Mazancourt P. Blood Coagul Fibrinolysis; 2002 Mar 07; 13(2):149-53. PubMed ID: 11914657 [Abstract] [Full Text] [Related]
20. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys]. Furlan M, Leupin L, Biasiutti FD, Lämmle B. Schweiz Med Wochenschr; 1991 Jul 20; 121(29):1068-71. PubMed ID: 1891701 [Abstract] [Full Text] [Related] Page: [Next] [New Search]